Boston Scientific [BSX] vs Dexcom [DXCM] Detailed Stock Comparison

Boston Scientific

NYSE

Dexcom

NASDAQ

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Boston Scientific wins in 13 metrics, Dexcom wins in 6 metrics, with 0 ties. Boston Scientific appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	Boston Scientific	Dexcom	Better
P/E Ratio (TTM)	60.80	56.46	Dexcom
Price-to-Book Ratio	6.78	12.22	Boston Scientific
Debt-to-Equity Ratio	53.09	100.24	Boston Scientific
PEG Ratio	36.83	39.49	Boston Scientific
EV/EBITDA	34.85	33.67	Dexcom
Profit Margin (TTM)	13.55%	13.29%	Boston Scientific
Operating Margin (TTM)	18.63%	18.37%	Boston Scientific
EBITDA Margin (TTM)	18.63%	18.37%	Boston Scientific
Return on Equity	11.55%	22.83%	Dexcom
Return on Assets (TTM)	5.39%	6.08%	Dexcom
Free Cash Flow (TTM)	$2.37B	$630.70M	Boston Scientific
1-Year Return	31.85%	8.44%	Boston Scientific
Price-to-Sales Ratio (TTM)	8.23	7.31	Dexcom
Enterprise Value	$163.98B	$31.09B	Boston Scientific
EV/Revenue Ratio	8.87	7.23	Dexcom
Gross Profit Margin (TTM)	67.65%	59.53%	Boston Scientific
Revenue per Share (TTM)	$13	$11	Boston Scientific
Earnings per Share (Diluted)	$1.69	$1.42	Boston Scientific
Beta (Stock Volatility)	0.66	1.44	Boston Scientific

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

Boston Scientific vs Dexcom Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Boston Scientific	-0.94%	0.03%	-0.30%	-1.61%	-2.07%	15.43%
Dexcom	1.24%	2.65%	-4.52%	-5.51%	-10.58%	3.12%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Boston Scientific	31.85%	145.53%	168.46%	531.01%	1,713.18%	274.35%
Dexcom	8.44%	-4.89%	-24.15%	259.78%	2,494.55%	2,653.40%

Performance Comparison

This comparison requires JavaScript for dynamic charts and real-time data. For complete performance analysis, visit the individual stock overview pages:

Boston Scientific (BSX): View Full Stock Overview

Dexcom (DXCM): View Full Stock Overview

The individual stock overview pages contain detailed performance metrics, historical charts, financial data, and comparison tools that work without JavaScript.

Key Performance Metrics Available:

Daily, weekly, monthly, and yearly returns
52-week high and low prices
Market capitalization and valuation ratios
Financial health and profitability metrics
Dividend history and yield information

Performance & Financial Health Analysis: Boston Scientific vs Dexcom

Metric	BSX	DXCM
Market Information
Market Cap i	$152.25B	$31.44B
Market Cap Category	Large cap	Large cap
10 Day Avg. Volume i	5,978,470	5,083,030
90 Day Avg. Volume i	7,119,910	3,546,350
Last Close	$103.17	$80.95
52 Week Range	$76.60 - $108.94	$57.52 - $93.25
% from 52W High	-5.30%	-13.19%
All-Time High	$108.94 (Jul 23, 2025)	$164.86 (Nov 15, 2021)
% from All-Time High	-5.30%	-50.90%
Growth Metrics
Quarterly Revenue Growth	0.23%	0.15%
Quarterly Earnings Growth	1.46%	0.25%
Financial Health
Profit Margin (TTM) i	0.14%	0.13%
Operating Margin (TTM) i	0.19%	0.18%
Return on Equity (TTM) i	0.12%	0.23%
Debt to Equity (MRQ) i	53.09	100.24
Cash & Liquidity
Book Value per Share (MRQ)	$15.14	$6.56
Cash per Share (MRQ)	$0.36	$7.47
Operating Cash Flow (TTM) i	$4.28B	$987.70M
Levered Free Cash Flow (TTM) i	$2.94B	$425.12M
Dividends
Last 12-Month Dividend Yield i	N/A	N/A
Last 12-Month Dividend i	N/A	N/A

Valuation & Enterprise Metrics Analysis: Boston Scientific vs Dexcom

Metric	BSX	DXCM
Price Ratios
P/E Ratio (TTM) i	60.80	56.46
Forward P/E i	36.83	39.49
PEG Ratio i	36.83	39.49
Price to Sales (TTM) i	8.23	7.31
Price to Book (MRQ) i	6.78	12.22
Market Capitalization
Market Capitalization i	$152.25B	$31.44B
Enterprise Value i	$163.98B	$31.09B
Enterprise Value Metrics
Enterprise to Revenue i	8.87	7.23
Enterprise to EBITDA i	34.85	33.67
Risk & Other Metrics
Beta i	0.66	1.44
Book Value per Share (MRQ) i	$15.14	$6.56

Financial Statements Comparison: Boston Scientific vs Dexcom

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	BSX	DXCM
Revenue/Sales i	$4.66B	$1.04B
Cost of Goods Sold i	$1.45B	$447.00M
Gross Profit i	$3.21B	$589.00M
Research & Development i	$443.00M	$145.20M
Operating Income (EBIT) i	$937.00M	$133.70M
EBITDA i	$1.23B	$219.00M
Pre-Tax Income i	$805.00M	$154.30M
Income Tax i	$133.00M	$48.90M
Net Income (Profit) i	$672.00M	$105.40M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	BSX	DXCM
Cash & Equivalents i	$725.00M	$904.90M
Total Current Assets i	$7.34B	$4.55B
Total Current Liabilities i	$5.06B	$3.04B
Long-Term Debt i	$10.93B	$1.36B
Total Shareholders Equity i	$22.45B	$2.27B
Retained Earnings i	$3.35B	$1.70B
Property, Plant & Equipment i	$448.00M	$59.10M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	BSX	DXCM
Operating Cash Flow i	$513.00M	$167.90M
Capital Expenditures i	$-187.00M	$-87.00M
Free Cash Flow i	$277.00M	$96.80M
Debt Repayment i	$-1.31B	N/A
Common Stock Repurchase i	N/A	N/A

Short Interest & Institutional Ownership Analysis

Metric	BSX	DXCM
Shares Short i	19.57M	8.49M
Short Ratio i	2.65	2.71
Short % of Float i	0.01%	0.03%
Average Daily Volume (10 Day) i	5,978,470	5,083,030
Average Daily Volume (90 Day) i	7,119,910	3,546,350
Shares Outstanding i	1.47B	390.70M
Float Shares i	1.48B	389.43M
% Held by Insiders i	0.00%	0.00%
% Held by Institutions i	0.93%	0.99%

Dividend Analysis & Yield Comparison: Boston Scientific vs Dexcom

Metric	BSX	DXCM
Last 12-Month Dividend i	N/A	N/A
Last 12-Month Dividend Yield i	N/A	N/A
3-Year Avg Annual Dividend i	N/A	N/A
3-Year Avg Dividend Yield i	N/A	N/A
3-Year Total Dividends i	N/A	N/A
Ex-Dividend Date	N/A	N/A

Boston Scientific [BSX] vs Dexcom [DXCM] Detailed Stock Comparison